Aurobindo Pharma Ltd. Unit-XII vs Guardian Drug Co. Inc.: FDA Enforcement Comparison

Guardian Drug Co. Inc. has been the subject of 23 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Aurobindo Pharma Ltd. Unit-XII.

Aurobindo Pharma Ltd. Unit-XII: 0 warning letters, 0 recalls, 0 approval records, 1 Form 483.

Guardian Drug Co. Inc.: 0 warning letters, 23 recalls, 0 approval records, 0 Form 483s.

Side by side

Aurobindo Pharma Ltd. Unit-XII — Warning letters0

Guardian Drug Co. Inc. — Warning letters0

Aurobindo Pharma Ltd. Unit-XII — Recalls0

Guardian Drug Co. Inc. — Recalls23

Aurobindo Pharma Ltd. Unit-XII — Approval records0

Guardian Drug Co. Inc. — Approval records0

Aurobindo Pharma Ltd. Unit-XII — Form 483s1

Guardian Drug Co. Inc. — Form 483s0

Timeline

Aurobindo Pharma Ltd. Unit-XII

Most recent FDA action: September 5, 2025

Full history →

Guardian Drug Co. Inc.

Most recent FDA action: June 10, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Aurobindo Pharma Ltd. Unit-XII vs Guardian Drug Co. Inc.: FDA Enforcement Comparison." Argus HQ, accessed July 13, 2026. https://argushq.ai/compare/aurobindo-pharma-ltd-unit-xii-vs-guardian-drug-co-inc

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗